Protein Frontiers ApS: Financial statements 2024
CVR: 43132709
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Protein Frontiers ApS (CVR 43132709) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 768,166 and a net result of DKK 601,274 compared with DKK 545,732 the year before. That is an increase of 25.9% compared with the year before. Equity in the 2024 report amounted to DKK 1,066,515. The solvency ratio was 97%.
- Gross Profit
- DKK 768,166
- Profit/Loss
- DKK 601,274
- Equity
- DKK 1,066,515
- Total Assets
- DKK 1,099,065
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 768 t. | 601 t. | 1.1 mio. | 0 |
| 2023 | - | 610 t. | 546 t. | 465 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Protein Frontiers ApS has published its annual report for 2023. Gross profit came to DKK 609,925, and the net result was DKK 545,732.
About Protein Frontiers ApS
Protein Frontiers ApS is a Danish company of the type Anpartsselskab based in Gentofte, founded in 2022. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Henrik Sønksen. The board consists of Niels Kristian Sørensen (chair), Peter Lübeck, Hans Peder Morten Laursen Meldgaard and Henrik Sønksen. The company's owners include MPLU Biorefining Aps, NKS Investment ApS and H Sønksen Holding ApS. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 513,139 and a net result of DKK -149,320 compared with DKK 601,274 the year before. Equity in the 2025 report amounted to DKK 1,183,824.